| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Jefferson Cancer Institute, Jefferson Cancer Center and Department of Microbiology and Immunology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107 [G. C., T. N., Y. G., O. C., R. P., C. M. C., E. C.]; St. Jude Children's Research Hospital, and the University of Tennessee, Memphis College of Medicine, Memphis, Tennessee 38101 [W. M. C.]; University of Alabama at Birmingham, Birmingham, Alabama 35294 [A. J. C.]; the Pediatric Oncology Group, St. Louis, Missouri 63108 [W. M. C. and A. J. C.]; Roswell Park Cancer Institute, Buffalo, New York 14623 [M. B., C. D. B.]; and University of Pennsylvania, Philadelphia, Pennsylvania 19104 [P. C. N.]
The 11q23 chromosome band is frequently associated with chromosomal aberrations in human leukemias. We have previously cloned a DNA fragment derived from chromosome 11 which could be used as a probe to detect rearrangements in DNAs from the leukemic cells of patients with the t(4;11), t(9;11), and t(11;19) translocations. In this study we now show that the same probe detects DNA rearrangements in malignant cells from patients with the t(1;11), t(6;11), t(10;11), and del (11q23) chromosomal abnormalities. A second probe obtained from a region located centrometric to the breakpoint cluster detects major and minor transcripts of 12.5 and 11.5 kilobases, respectively, in all cell lines examined. The same probe identifies an altered 11-kilobase RNA in all three independent cell lines with the t(4;11)(q21;q23) chromosome translocation.
1 Supported by an Outstanding Investigation Grant (CA39860) to C. M. C. from the National Cancer Institute and National Cancer Institute Grants CA30969, CA31566, and CA21765.
2 To whom requests for reprints should be addressed.
Received 4/28/92. Accepted 5/26/92.
This article has been cited by other articles:
![]() |
P. Isnard, N. Core, P. Naquet, and M. Djabali Altered lymphoid development in mice deficient for the mAF4 proto-oncogene Blood, July 15, 2000; 96(2): 705 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Uckun, K. Herman-Hatten, M.-L. Crotty, M. G. Sensel, H. N. Sather, L. Tuel-Ahlgren, M. B. Sarquis, B. Bostrom, J. B. Nachman, P. G. Steinherz, et al. Clinical Significance of MLL-AF4 Fusion Transcript Expression in the Absence of a Cytogenetically Detectable t(4;11)(q21;q23) Chromosomal Translocation Blood, August 1, 1998; 92(3): 810 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Thirman, H. J. Gill, R. C. Burnett, D. Mbangkollo, N. R. McCabe, H. Kobayashi, S. Ziemin-van der Poel, Y. Kaneko, R. Morgan, A. A. Sandberg, et al. Rearrangement of the MLL Gene in Acute Lymphoblastic and Acute Myeloid Leukemias with 11q23 Chromosomal Translocations N. Engl. J. Med., September 23, 1993; 329(13): 909 - 914. [Abstract] [Full Text] |
||||
![]() |
P. J. Kourlas, M. P. Strout, B. Becknell, M. L. Veronese, C. M. Croce, K. S. Theil, R. Krahe, T. Ruutu, S. Knuutila, C. D. Bloomfield, et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: Evidence for its fusion with MLL in acute myeloid leukemia PNAS, February 29, 2000; 97(5): 2145 - 2150. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |